Get started
RocketTickers

Ultragenyx Announces Positive Topline Cohort 3 Results and Impro

Long
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)  
RocketTickers  
NASDAQ:RARE   Ultragenyx Pharmaceutical Inc.
Beyond Technical Analysis
7
0
beyondta
RARE: Ultragenyx Pharmaceutical Inc.
2020-01-09 16:01:10
Ultragenyx Announces Positive Topline Cohort 3 Results and Improved Longer-Term Cohort 2 Results from Phase 1/2 Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.